Viewing Study NCT06305780



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2025-12-16 @ 11:15 PM
Study NCT ID: NCT06305780
Status: None
Last Update Posted: 2025-07-23 00:00:00
First Post: 2024-03-04 00:00:00

Brief Title: RECOVER-AUTONOMIC Platform Protocol
Sponsor: Kanecia Obie Zimmerman
Organization: Duke University

Study Overview

Official Title: RECOVER-AUTONOMIC: A Platform Protocol for Evaluation of Interventions for Autonomic Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Status: None
Status Verified Date: 2025-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The hypothesis is that some of the autonomic dysfunction symptoms are immune-mediated, so immunotherapy and other applicable therapies will result in improvement in autonomic symptoms.

Interventions will be added to the platform protocol as appendices. Each appendix will leverage all elements of the platform protocol, with additional elements described in the individual appendix.
Detailed Description: The hypothesis is that some of the autonomic dysfunction symptoms are immune-mediated so immunotherapy and other applicable therapies will result in improvement in autonomic symptoms

Interventions will be added to the platform protocol as appendices Each appendix will leverage all elements of the platform protocol with additional elements described in the individual appendix

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
OTA-21-015G OTHER NIH Grant to RTI RTI subcontracting with DCRI None